Tag: checkpoint

PHILADELPHIA and VANCOUVER, British Columbia, July 11, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company developing novel immunotherapies to transform cancer care, today announced updated Phase 2 survival data for its lead immunotherapy candidate, Bria-IMT, in combination with an immune check point inhibitor (CPI).

PARIS and CAMBRIDGE, Mass., July 07, 2025 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company’’),  a late-stage clinical biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, today announced two important developments that aim to reinforce the global positioning of potential first-in-class radioenhancer JNJ-1900 (NBTXR3), which is licensed by Janssen Pharmaceutica NV, a Johnson & Johnson company.

Washington, DC, July 06, 2025 (GLOBE NEWSWIRE) -- Research firm CryptoVision projects Solana (SOL) to revisit US $200-$220 and XRP to reclaim US $1.50-$1.80 before year-end. While most retail traders chase those targets with spot buys, MGPD Finance Limited, doing business as hashj cloud mining offers a smarter path: its new Turbo-Yield Dual-Engine Cloud Lane mines both assets in real time, turning price forecasts into compounding daily income. Every new registrant receives an $18 welcome credit plus $100 of free hash power—no hardware, no configuration, instant earnings.

Data show confirmed ORR of 83% (10/12) at doses selected for ongoing expansion study